These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1385479)

  • 61. Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis.
    Ursini F; D'Angelo S; Russo E; Nicolosi K; Gallucci A; Chiaravalloti A; Bruno C; Naty S; De Sarro G; Olivieri I; Grembiale RD
    PLoS One; 2016; 11(9):e0163464. PubMed ID: 27656896
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduced immune function predicts disease susceptibility in frogs infected with a deadly fungal pathogen.
    Savage AE; Terrell KA; Gratwicke B; Mattheus NM; Augustine L; Fleischer RC
    Conserv Physiol; 2016; 4(1):cow011. PubMed ID: 27293759
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
    Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
    Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complement system in dermatological diseases - fire under the skin.
    Panelius J; Meri S
    Front Med (Lausanne); 2015; 2():3. PubMed ID: 25688346
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Complement factor I promotes progression of cutaneous squamous cell carcinoma.
    Riihilä P; Nissinen L; Farshchian M; Kivisaari A; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2015 Feb; 135(2):579-588. PubMed ID: 25184960
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of complement C3a receptor responses by kallikrein-related peptidase 14.
    Oikonomopoulou K; DeAngelis RA; Chen H; Diamandis EP; Hollenberg MD; Ricklin D; Lambris JD
    J Immunol; 2013 Oct; 191(7):3858-66. PubMed ID: 24014879
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
    Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Staphylococcal proteases aid in evasion of the human complement system.
    Jusko M; Potempa J; Kantyka T; Bielecka E; Miller HK; Kalinska M; Dubin G; Garred P; Shaw LN; Blom AM
    J Innate Immun; 2014; 6(1):31-46. PubMed ID: 23838186
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The complement system at the embryo implantation site: friend or foe?
    Bulla R; Bossi F; Tedesco F
    Front Immunol; 2012; 3():55. PubMed ID: 22566936
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultraviolet-B recruits mannose-binding lectin into skin from non-cutaneous sources.
    Lokitz ML; Zhang W; Bashir M; Sullivan KE; Ang G; Kwon EJ; Lin JH; Werth VP
    J Invest Dermatol; 2005 Jul; 125(1):166-73. PubMed ID: 15982317
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).
    Repik A; Pincus SE; Ghiran I; Nicholson-Weller A; Asher DR; Cerny AM; Casey LS; Jones SM; Jones SN; Mohamed N; Klickstein LB; Spitalny G; Finberg RW
    Clin Exp Immunol; 2005 May; 140(2):230-40. PubMed ID: 15807846
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunology of diseases associated with Malassezia species.
    Ashbee HR; Evans EG
    Clin Microbiol Rev; 2002 Jan; 15(1):21-57. PubMed ID: 11781265
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance.
    Hammerberg C; Katiyar SK; Carroll MC; Cooper KD
    J Exp Med; 1998 Apr; 187(7):1133-8. PubMed ID: 9529329
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes.
    Pascual M; Steiger G; Sadallah S; Paccaud JP; Carpentier JL; James R; Schifferli JA
    J Exp Med; 1994 Mar; 179(3):889-99. PubMed ID: 8113681
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression and localization of proteins of the complement system in human skin.
    Dovezenski N; Billetta R; Gigli I
    J Clin Invest; 1992 Nov; 90(5):2000-12. PubMed ID: 1385479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of complement receptor CR2 (CD21) on human subcorneal keratinocytes in normal and diseased skin.
    Hunyadi J; Simon M; Kenderessy AS; Dobozy A
    Dermatologica; 1991; 183(3):184-6. PubMed ID: 1835941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
    Seya T; Okada M; Hara T; Matsumoto M; Miyagawa S; Oshimura M
    Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Cell-associated complement regulatory proteins and their relation to disease processes].
    Seya T
    Rinsho Byori; 1991 Dec; 39(12):1317-24. PubMed ID: 1723433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.